tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks
PremiumRatingsCautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks
2M ago
DBV Technologies reinstated with a Sell at Goldman Sachs
Premium
The Fly
DBV Technologies reinstated with a Sell at Goldman Sachs
2M ago
DBV Technologies price target raised to $21 from $15 at Citizens JMP
Premium
The Fly
DBV Technologies price target raised to $21 from $15 at Citizens JMP
2M ago
DBVT Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsDBVT Upcoming Earnings Report: What to Expect?
3M ago
DBV Technologies Advances Viaskin Peanut Patch with FDA
Premium
Company Announcements
DBV Technologies Advances Viaskin Peanut Patch with FDA
3M ago
DBV Technologies Delays 10-K Filing Amid Financing Efforts
Premium
Company Announcements
DBV Technologies Delays 10-K Filing Amid Financing Efforts
4M ago
DBV reports VITESSE trial sufficient to support BLA, discontinues COMFORT trial
PremiumThe FlyDBV reports VITESSE trial sufficient to support BLA, discontinues COMFORT trial
4M ago
DBV Technologies S.A. – American Depositary Shares (DBVT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
DBV Technologies S.A. – American Depositary Shares (DBVT) Q4 Earnings Cheat Sheet
5M ago
Viaskin Peanut: A Promising Non-Invasive Solution for Children’s Peanut Allergies with Strong Market Potential
Premium
Ratings
Viaskin Peanut: A Promising Non-Invasive Solution for Children’s Peanut Allergies with Strong Market Potential
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100